Precision Diagnosis of Cancers Based on Artificial Intelligence Pathology Analysis
Artificial intelligence (AI) is expected to play a vital role in the new era of precision pathology diagnosis. Combining cutting-edge AI and WSI technology can integrate patient clinical information, multi-omics data, and tissue pathology images to facilitate precision diagnosis. Several studies have demonstrated the power of AI by developing an automated histopathological evaluation system for tumors. This tool can improve the accuracy of adult tumor pathology and clinical diagnosis, save time and cost, and also open up a new way to predict patient prognosis and molecular changes. Despite the rapid development of AI and WSI, powerful AI models are still in high demand.
Therefore, to improve the effectiveness and accuracy of clinical diagnosis, facilitate disease prediction and timely treatment of tumors, and save time and costs for the family, it is imperative to develop powerful AI tools for various cancer pathological diagnoses. To develop a smart AI model, large numbers of pathology images are highly required for model training.
This project will first collect the WSI images and clinical information of cancer patients, and use these data to train and develop an automated AI system. We envision that this new technology can be a versatile tool to improve the accuracy of clinical diagnosis, facilitate disease prediction and timely treatment of tumors, and save time and costs for the family. This tool can also be used to assist in the training of cancer pathologists. In addition, our results may facilitate the cancer etiology elucidation and drug discovery, and potentially improve the quality of life and survival rate of cancer patients.
This project will develop a new artificial intelligence (AI) system for the automated diagnosis of tumors through pathological images recorded by whole slide imaging (WSI) technology. We envision that this new technology can improve the accuracy of clinical diagnosis, facilitate disease prediction and timely treatment of cancers, and save time and costs for the family. Also, we hope this technology can help improve the quality of life and survival rate of cancer patients.
To achieve our goals, the following steps will be conducted:
①Image acquisition: collect whole slide images and clinical information on cancer patients.
②Preprocessing: converting the digital images into a format suitable for analysis, including normalization, filtering, and segmentation.
③Feature extraction: identifying and extracting relevant features from the digital images, such as morphological, textural, and intensity-based features.
④Phenotypic characterization: analyzing the extracted features to characterize the phenotypic characteristics of the tissue samples, including cellularity, nuclear morphology, and tissue architecture.
⑤Association analysis: investigating the association between the phenotypic characteristics and genetic variants, if applicable. This may involve techniques such as genome-wide association studies (GWAS) or machine learning approaches.
⑥Validation: validating the findings through independent cohorts or experimental evidence.
Dr. Xiyue Wang, a postdoc fellow recenly joined in the Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 USA (e-mail: xiyue.wang.scu@gmail.com)